7/8
Review
N/A
et al., Cell Death & Disease volume 11, doi:10.1038/s41419-020-2721-8 (Review) (Peer Reviewed) (not included in the study count)
Is hydroxych loroquine beneficial for COVID-19 patients?
Review of the anti-inflammatory, antiviral, and protective vascular effects of C Q and HC Q, noting that HC Q may be preferable for COVID-19 due to fewer side effects.